Annals of Hematology

, Volume 87, Issue 6, pp 505–508 | Cite as

Mast cell leukemia: a report of ten cases

  • Caterina Giovanna Valentini
  • Michela Rondoni
  • Enrico Maria Pogliani
  • Maria Teresa Van Lint
  • Chiara Cattaneo
  • Laura Marbello
  • Alessandro Pulsoni
  • Fiorina Giona
  • Giovanni Martinelli
  • Giuseppe Leone
  • Livio Pagano
Letter to the Editor

References

  1. 1.
    Valent P, Horny H-P, Escribano L, Longley BJ, Li CY, Scwhartz LB, Marone G, Nunez R, Akin C, Sotlar K, Sperr WR, Wolff K, Brunning RD, Parwaresch RM, Austen KF, Lennert K, Metcalfe DD, Vardiman JW, Bennett JM (2001) Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 25:603–625PubMedCrossRefGoogle Scholar
  2. 2.
    Valent P, Akin C, Sperr WR, Horny HP, Arock M, Lechner K, Bennett JM, Metcalfe DD (2003) Diagnosis and treatment of systemic mastocytosis: state of the art. Br J Haematol 122:695–717PubMedCrossRefGoogle Scholar
  3. 3.
    Horny HP, Sotlar K, Valent P (2007) Mastocytosis: state of the art. Pathobiology 74(2):121–132PubMedCrossRefGoogle Scholar
  4. 4.
    Valent P, Horny HP, Li CY, Longley JB, Metcalfe DD, Parwaresch RM, Bennett J (2001) Mastocytosis (mast cell disease). In: Jaffe ES, Harris NL, Stein H, Vardman J (eds) World Health Organization (WHO) classification of tumours. Pathology and genetics. Tumours of haematopoietic and lymphoid tissue 1. WHO, Geneva, pp 291–302Google Scholar
  5. 5.
    Valent P, Akin C, Sperr WR, Escribano L, Arock M, Horny HP, Bennet JM, Metcalfe DD (2003) Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria. Leuk Res 27:635–641PubMedCrossRefGoogle Scholar
  6. 6.
    Noack F, Sotlar K, Notter M, Thiel E, Valent P, Horny HP (2004) Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816V. Leuk Lymphoma 45(11):2295–2302PubMedCrossRefGoogle Scholar
  7. 7.
    Hennessy B, Giles F, Cortes J, O’brien S, Ferrajoli A, Ossa G, Garcia-Manero G, Faderl S, Kantarjian H, Verstovsek S (2004) Management of patients with systemic mastocytosis: review of M. D. Anderson Cancer Center experience. Am J Hematol 77:209–214PubMedCrossRefGoogle Scholar
  8. 8.
    Pardanani A, Elliott M, Reeder T, Li CY, Baxter EJ, Cross NC, Tefferi A (2003) Imatinib for systemic mast-cell disease. Lancet 362(9383):535–536PubMedCrossRefGoogle Scholar
  9. 9.
    Spyridonidis A, Thomas AK, Bertz H, Zeiser R, Schimitt-Graff A, Lindemann A, Waller CF, Finke J (2004) Evidence for a graft-versus-mast-cell effect after allogeneic bone marrow transplantation. Bone Marrow Transplant 34(6):515–519PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Caterina Giovanna Valentini
    • 1
  • Michela Rondoni
    • 2
  • Enrico Maria Pogliani
    • 3
  • Maria Teresa Van Lint
    • 4
  • Chiara Cattaneo
    • 5
  • Laura Marbello
    • 6
  • Alessandro Pulsoni
    • 7
  • Fiorina Giona
    • 7
  • Giovanni Martinelli
    • 2
  • Giuseppe Leone
    • 1
  • Livio Pagano
    • 1
  1. 1.Istituto di EmatologiaUniversità Cattolica del Sacro CuoreRomeItaly
  2. 2.Istituto di Ematologia L. e A. SeragnoliUniversità di BolognaBolognaItaly
  3. 3.Divisione di EmatologiaOspedale S. GerardoMonzaItaly
  4. 4.Centro Trapianti di MidolloOspedale S. MartinoGenovaItaly
  5. 5.Divisione di EmatologiaSpedali Civili di BresciaBresciaItaly
  6. 6.Divisione di EmatologiaOspedale Niguarda Ca’ GrandaMilanItaly
  7. 7.Istituto di EmatologiaUniversità “La Sapienza”RomeItaly

Personalised recommendations